What does Veradermics, Inc do?

Veradermics, Inc is a public company in the Pharmaceutical Preparations industry, incorporated in DE. It is registered with the SEC under CIK 0001827635 and trades on NYSE under the ticker MANE.

Is Veradermics, Inc profitable?

Veradermics, Inc reported a net loss of $70.00M in FY2025. This figure is sourced from its SEC EDGAR 10-K annual report.

How many SEC filings has Veradermics, Inc made?

Veradermics, Inc has filed 48 documents with the SEC since 2020. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

Veradermics, Inc

MANE NYSE CIK: 0001827635 Pharmaceutical Preparations Inc. in DE

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 48 filings →

Form	Description	Date
4/A	FORM 4/A	Feb 27, 2026
SCHEDULE 13D	—	Feb 12, 2026
SCHEDULE 13G	—	Feb 12, 2026
SCHEDULE 13D	—	Feb 11, 2026
SCHEDULE 13D	—	Feb 11, 2026
4	—	Feb 9, 2026
3	—	Feb 9, 2026
4	4	Feb 5, 2026
4	FORM 4	Feb 5, 2026
4	FORM 4	Feb 5, 2026

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for Veradermics, Inc. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Net Income: ($70.00M) (FY2025)
Total Assets: $152.62M (FY2025)
Operating Income: ($72.35M)

Full financials →

Details

CIK: 0001827635
Ticker: MANE
Exchange: NYSE
Incorporated: DE
First Filing: 2020
Total Filings: 48

Pharmaceutical Preparations rankings →